middle.news
How Will Genetic Signatures Navigate CEO Departure Amid Global Growth?
8:32am on Tuesday 20th of January, 2026 AEDT
•
Healthcare
Read Story
How Will Genetic Signatures Navigate CEO Departure Amid Global Growth?
8:32am on Tuesday 20th of January, 2026 AEDT
Key Points
Q2 FY26 sales of $3.3 million with seasonal dip in Australian respiratory testing
International markets, including US and UK NHS, contribute increasing revenue
Progress on automated, high-throughput diagnostic platform development
Strong cash reserves of $29.7 million supported by R&D tax incentive
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Signatures (ASX:GSS)
OPEN ARTICLE